For those that are confused on the expected trial completion-
Recruitment of patients into the trial is on track to complete dosing of all 92 patients before the recruitment target of the end of calendar year 2025.
Clearly states BEFORE target end of 2025 year. This is extremely encouraging. Do the math based on current patients enrolled.
Ann: Phase 2 Stroke Clinical Trial Update, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
-0.070(8.05%) |
Mkt cap ! $98.96M | |||
| Open | High | Low | Value | Volume |
| 88.0¢ | 89.0¢ | 80.0¢ | $400.5K | 480.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 54310 | 80.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.0¢ | 17400 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |